Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ImmunoGen -- Ignore unavailable to you. Want to Upgrade?

To: RJMC who wrote (2984)	4/5/2000 10:01:00 PM
From: Gary Mohilner	Read Replies (1) \| Respond to of 5665

I think what's been shown this week is pretty much the results that have been documented on the website. I know it's dissapointing not to have seen something, but I believe they'll use their time and P.R. budget where it will get greater long term growth. I went into much more depth on R.B., but I believe we'll see P.R. for new information, like the Prostate Drug, new Partnerships, renewal of the BCHE Partnership, Milestones, and most importantly, Efficacy. Remember, Conference attendees have yet to go home, while the data was not new to us, it must have been to some of them. I suspect we'll see some investors and some recommendations come out of this conference. It was held in McCamant's home town, I've got to believe that he and other analysts attended and will make their thoughts known once it's over. Gary